drugset / Trial / NCT03661346
Esmolol vs. Labetalol in Endoscopic Sinus Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare esmolol and labetalol bleeding and intra-operative visibility scores in functional endoscopic sinus surgery.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2018-03-30
- Completion
- 2018-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | 0.3 mg/kg | — |
| Comparator | Labetalol | Small molecule | 20 mg | — |